Nasyrova, Regina F.,
Khasanova, Aiperi K.,
Altynbekov, Kuanysh S.,
Asadullin, Azat R.,
Markina, Ekaterina A.,
Gayduk, Arseny J.,
Shipulin, German A.,
Petrova, Marina M.,
Shnayder, Natalia A. (2022) the search for new therapeutic strategies for a
disease-modifying therapy for treatment-resistant Sch (TRS
Влияние транспозонов на развитие болезни АльцгеймераInvolvement of transposable elements in Alzheimer’s
disease pathogenesis
Ronkainen, J.,
Nedelec, R.,
Atehortua, A.,
Balkhiyarova, Z.,
Cascarano, A.,
Dang, V.N.,
Elhakeem, A.,
Van Enckevort, E.,
Soares, A.G.,
Haakma, S.,
Halonen, M.,
Heilb, K.F. (2022) The current epidemics of cardiovascular and metabolic noncommunicable
diseases have emerged
Khidiyatova, I.M.,
Saifullina, E.V.,
Karunas, A.S.,
Akhmetgaleyeva, A.F.,
Kutlubaeva, R.F.,
Smakova, L.A.,
Lobov, S.L.,
Polyakov, A.V.,
Shchagina, O.A.,
Kadnikova, V.A.,
Ryzhkova, O.P.,
Magzhanov, R.V. (2022) was established. The clinical symptoms of the
disease in most cases correspond to uncomplicated HSP occurring in a
of bronchopulmonary
diseases of patients in hospital conditions. The description of the process of treatment taking
Dorling, L.,
Carvalho, S.,
Allen, J.,
González-Neira, A.,
Luccarini, C.,
Wahlström, C.,
Pooley, K.A.,
Parsons, M.T.,
Fortuno, C.,
Wang, Q.,
Bolla, M.K.,
Dennis, J.,
Bermisheva, M.,
Khusnutdinova, E.,
Prokofyeva, D.,
other additional authors (2021) )-positive
disease than for ER-negative
disease; for protein-truncating variants in BARD1, BRCA1, BRCA2, PALB2, RAD51